Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Ahram Canadian University

Status: Terminated

Conditions: Chronic Atopic Dermatitis

Treatments: Drug: Topical corticosteroid ointment; Device: polarized light

Study type: Observational

Funder types: Other

Identifiers

NCT04955951

AhramCUE

Details and patient eligibility

About

Non-atopic dermatitis (NAD) or eczema is a common inflammatory condition; potentially debilitating that can compromise quality of life. It is usually seen in childhood, but can onset within or persist into adulthood.

Full description

Polarized ultraviolet-free polychromatic light is used as therapeutic option for the treatment of wound healing and dermatological conditions.

40 male patients who had atopic dermatitis in the chronic stage, they were complaining from itching, inflammation and skin thickness in the arm, wrist, hand and leg will participate in this study.

Enrollment: 40 patients

Sex: Male

Ages: 20 to 30 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patients' ages will ranged from 20 to 30 years.
• The subjects will be males.
• The duration of disease less than 1 year.

Exclusion criteria

• patients who had skin malignancy in the area to be treated.
• The patients who had history of diabetes, circulatory or sensory disorders.
• Patients with acute infection in the area treated.

Trial design

40 participants in 2 patient groups

polarized light group

Description:

group A (20 patients) will receive Polarized light therapy

Treatment:

Device: polarized light

topical corticosteroid group

Description:

group B (20 patients) will receive topical corticosteroid therapy

Treatment:

Drug: Topical corticosteroid ointment